Drug Type Small molecule drug |
Synonyms KN 510713, KN510713 |
Target |
Action inhibitors, blockers |
Mechanism ACAA1 inhibitors(acetyl-CoA acyltransferase 1 inhibitors), SLC25A20 blockers(solute carrier family 25 member 20 blockers) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | South Korea | 22 Oct 2025 | |
Pancreatic Cancer | Preclinical | South Korea | 28 Apr 2025 |